Department of Urology, Grenoble Alpes University Hospital, Grenoble, France.
Department of Urology, Nantes University Hospital, Nantes, France.
Int Urogynecol J. 2022 Apr;33(4):767-776. doi: 10.1007/s00192-021-04929-1. Epub 2021 Aug 17.
The aim of our study was to evaluate the efficiency and safety of synthetic mid-urethral slings (sMUS) for the treatment of stress urinary incontinence (SUI) in women with neurogenic lower urinary tract dysfunction (NLUTD).
A systematic review was performed and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. MEDLINE, Embase and Cochrane controlled trials databases were systematically searched from January 1995 to April 2021. Studies including adult women with NLUTD who had a sMUS for SUI were considered for inclusion. Primary outcome was success of the surgery according to study criteria. Secondary outcomes were complications, especially de novo urgency, urinary retention, tape exposure and revision for complications.
A total of 752 abstracts were screened and 9 studies were included, representing 298 patients. The mean age was 52 years and median follow-up was 41.3 months. sMUS insertion was successful in 237 patients (79.5%). The median rate of de novo urgency was 15.7% (range 8.3-30%). In patients with spontaneous voiding, the median rate of retention was 19.3% (range 0-46.7%) and 21 out of 26 patients required intermittent self-catheterisation. Four cases of tape exposure were reported, and 8 patients underwent a revision for complications.
This review suggests that sMUS might offer interesting success rates and acceptable morbidity and could be considered for the treatment of SUI in women with NLUTD. Further studies are required to define which patients would be more likely to benefit from this intervention, as well as its place among the other surgical treatments for SUI.
我们研究的目的是评估合成中尿道吊带(sMUS)治疗伴有神经源性下尿路功能障碍(NLUTD)的女性压力性尿失禁(SUI)的疗效和安全性。
我们进行了系统评价,并按照系统评价和荟萃分析报告的首选报告项目进行了报告。系统检索了 1995 年 1 月至 2021 年 4 月期间的 MEDLINE、Embase 和 Cochrane 对照试验数据库。纳入研究包括伴有 NLUTD 的成年女性 SUI 患者,使用 sMUS 治疗。主要结局是根据研究标准评估手术成功情况。次要结局是并发症,特别是新发急迫性尿失禁、尿潴留、吊带暴露和并发症修复。
共筛选出 752 篇摘要,纳入 9 项研究,共 298 例患者。平均年龄为 52 岁,中位随访时间为 41.3 个月。237 例(79.5%)患者的 sMUS 植入成功。新发急迫性尿失禁的中位数发生率为 15.7%(范围 8.3-30%)。在有自主排尿的患者中,尿潴留的中位数发生率为 19.3%(范围 0-46.7%),26 例中有 21 例需要间歇性自我导尿。有 4 例报道了吊带暴露,8 例患者因并发症进行了修复。
本综述表明,sMUS 可能提供较高的成功率和可接受的发病率,可考虑用于治疗伴有 NLUTD 的女性 SUI。需要进一步研究来确定哪些患者更有可能从这种干预中获益,以及它在治疗 SUI 的其他手术治疗方法中的地位。